{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:19:56Z","timestamp":1791472796271,"version":"4.3.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["A4220530"],"award-info":[{"award-number":["A4220530"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22275056"],"award-info":[{"award-number":["22275056"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271434"],"award-info":[{"award-number":["32271434"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China Guangzhou First People's Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-64432-9","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:30:14Z","timestamp":1761125414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Reno-protective CT contrast nanoagent targets proximal tubular epithelium for kidney disease imaging and repair in a mouse model"],"prefix":"10.1038","volume":"16","author":[{"given":"Mingze","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4866-6695","authenticated-orcid":false,"given":"Yuming","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2960-6677","authenticated-orcid":false,"given":"Yexi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6871-1530","authenticated-orcid":false,"given":"Huixu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9008-9706","authenticated-orcid":false,"given":"Yiqiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8154-2277","authenticated-orcid":false,"given":"Ziyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6776-4996","authenticated-orcid":false,"given":"Yuming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1725-5221","authenticated-orcid":false,"given":"Xingya","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5625-8521","authenticated-orcid":false,"given":"Bujie","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"64432_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis, A. et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat. Rev. Nephrol. 20, 473\u2013485 (2024).","journal-title":"Nat. Rev. Nephrol."},{"key":"64432_CR2","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1681\/ASN.2005101106","volume":"17","author":"X Wang","year":"2006","unstructured":"Wang, X. et al. Validation of creatinine-based estimates of GFR when evaluating risk factors in longitudinal studies of kidney disease. J. Am. Soc. Nephrol. 17, 2900\u20132909 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"64432_CR3","doi-asserted-by":"publisher","first-page":"101821","DOI":"10.1016\/j.media.2020.101821","volume":"67","author":"N Heller","year":"2021","unstructured":"Heller, N. et al. The state of the art in kidney and kidney tumor segmentation in contrast-enhanced CT imaging: results of the KiTS19 challenge. Med. Image Anal. 67, 101821 (2021).","journal-title":"Med. Image Anal."},{"key":"64432_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41585-019-0148-8","volume":"16","author":"A Ferrero","year":"2019","unstructured":"Ferrero, A. et al. Understanding, justifying, and optimizing radiation exposure for CT imaging in nephrourology. Nat. Rev. Urol. 16, 231\u2013244 (2019).","journal-title":"Nat. Rev. Urol."},{"key":"64432_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1053\/j.ajkd.2023.02.007","volume":"82","author":"ST Francis","year":"2023","unstructured":"Francis, S. T., Selby, N. M. & Taal, M. W. Magnetic resonance imaging to evaluate kidney structure, function, and pathology: moving toward clinical application. Am. J. Kidney Dis. 82, 491\u2013504 (2023).","journal-title":"Am. J. Kidney Dis."},{"key":"64432_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1053\/j.ackd.2017.03.006","volume":"24","author":"JL Zhang","year":"2017","unstructured":"Zhang, J. L. Functional magnetic resonance imaging of the kidneys-with and without gadolinium-based contrast. Adv. Chronic Kidney Dis. 24, 162\u2013168 (2017).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"64432_CR7","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/s41578-021-00328-6","volume":"6","author":"P Cheng","year":"2021","unstructured":"Cheng, P. & Pu, K. Molecular imaging and disease theranostics with renal-clearable optical agents. Nat. Rev. Mater. 6, 1095\u20131113 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"64432_CR8","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1136\/bmj.324.7345.1077","volume":"324","author":"CJ Garvey","year":"2002","unstructured":"Garvey, C. J. Hanlon R. Computed tomography in clinical practice. BMJ 324, 1077\u20131080 (2002).","journal-title":"BMJ"},{"key":"64432_CR9","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1056\/NEJMra1805256","volume":"380","author":"R Mehran","year":"2019","unstructured":"Mehran, R., Dangas, G. D. & Weisbord, S. D. Contrast-associated acute kidney injury. N. Engl. J. Med. 380, 2146\u20132155 (2019).","journal-title":"N. Engl. J. Med."},{"key":"64432_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrneph.2016.196","volume":"13","author":"M F\u00e4hling","year":"2017","unstructured":"F\u00e4hling, M., Seeliger, E., Patzak, A. & Persson, P. B. Understanding and preventing contrast-induced acute kidney injury. Nat. Rev. Nephrol. 13, 169\u2013180 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"64432_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.7150\/thno.79625","volume":"13","author":"Z Jiang","year":"2023","unstructured":"Jiang, Z., Zhang, M., Li, P., Wang, Y. & Fu, Q. Nanomaterial-based CT contrast agents and their applications in image-guided therapy. Theranostics 13, 483\u2013509 (2023).","journal-title":"Theranostics"},{"key":"64432_CR12","doi-asserted-by":"publisher","first-page":"6655","DOI":"10.1021\/acsnano.5b01320","volume":"9","author":"M Yu","year":"2015","unstructured":"Yu, M. & Zheng, J. Clearance pathways and tumor targeting of imaging nanoparticles. ACS Nano 9, 6655\u20136674 (2015).","journal-title":"ACS Nano"},{"key":"64432_CR13","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1002\/anie.201807847","volume":"58","author":"M Yu","year":"2019","unstructured":"Yu, M., Xu, J. & Zheng, J. Renal clearable luminescent gold nanoparticles: from the bench to the clinic. Angew. Chem. Int. Ed. 58, 4112\u20134128 (2019).","journal-title":"Angew. Chem. Int. Ed."},{"key":"64432_CR14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41578-018-0038-3","volume":"3","author":"B Du","year":"2018","unstructured":"Du, B., Yu, M. & Zheng, J. Transport and interactions of nanoparticles in the kidneys. Nat. Rev. Mater. 3, 358\u2013374 (2018).","journal-title":"Nat. Rev. Mater."},{"key":"64432_CR15","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41581-024-00819-z","volume":"20","author":"Y Huang","year":"2024","unstructured":"Huang, Y. et al. Physiological principles underlying the kidney targeting of renal nanomedicines. Nat. Rev. Nephrol. 20, 354\u2013370 (2024).","journal-title":"Nat. Rev. Nephrol."},{"key":"64432_CR16","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/nnano.2017.170","volume":"12","author":"B Du","year":"2017","unstructured":"Du, B. et al. Glomerular barrier behaves as an atomically precise bandpass filter in a sub-nanometre regime. Nat. Nanotechnol. 12, 1096\u20131102 (2017).","journal-title":"Nat. Nanotechnol."},{"key":"64432_CR17","doi-asserted-by":"publisher","first-page":"20825","DOI":"10.1021\/acsnano.3c05853","volume":"17","author":"M Xu","year":"2023","unstructured":"Xu, M. et al. Size-dependent in vivo transport of nanoparticles: implications for delivery, targeting, and clearance. ACS Nano 17, 20825\u201320849 (2023).","journal-title":"ACS Nano"},{"key":"64432_CR18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2403131121","volume":"121","author":"Y Huang","year":"2024","unstructured":"Huang, Y., Yu, M. & Zheng, J. Charge barriers in the kidney elimination of engineered nanoparticles. Proc. Natl. Acad. Sci. USA. 121, e2403131121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"64432_CR19","doi-asserted-by":"publisher","first-page":"16039","DOI":"10.1002\/anie.201609043","volume":"55","author":"S Tang","year":"2016","unstructured":"Tang, S. et al. Tailoring renal clearance and tumor targeting of ultrasmall metal nanoparticles with particle density. Angew. Chem. Int. Ed. 55, 16039\u201316043 (2016).","journal-title":"Angew. Chem. Int. Ed."},{"key":"64432_CR20","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1002\/ange.201511148","volume":"128","author":"M Yu","year":"2016","unstructured":"Yu, M. et al. Noninvasive staging of kidney dysfunction enabled by renal-clearable luminescent gold nanoparticles. Angew. Chem. Int. Ed. 128, 2837\u20132841 (2016).","journal-title":"Angew. Chem. Int. Ed."},{"key":"64432_CR21","doi-asserted-by":"publisher","first-page":"2402479","DOI":"10.1002\/adma.202402479","volume":"36","author":"X Ning","year":"2024","unstructured":"Ning, X. et al. Gold nanoparticle transport in the injured kidneys with elevated renal function biomarkers. Adv. Mate. 36, 2402479 (2024).","journal-title":"Adv. Mate."},{"key":"64432_CR22","doi-asserted-by":"publisher","first-page":"15434","DOI":"10.1002\/anie.201507868","volume":"54","author":"M Yu","year":"2015","unstructured":"Yu, M., Liu, J., Ning, X. & Zheng, J. High-contrast noninvasive imaging of kidney clearance kinetics enabled by renal clearable nanofluorophores. Angew. Chem. Int. Ed. 54, 15434\u201315438 (2015).","journal-title":"Angew. Chem. Int. Ed."},{"key":"64432_CR23","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.1002\/ange.201901525","volume":"131","author":"X Jiang","year":"2019","unstructured":"Jiang, X., Du, B., Tang, S., Hsieh, J. T. & Zheng, J. Photoacoustic imaging of nanoparticle transport in the kidneys at high temporal resolution. Angew. Chem. Int. Ed. 131, 6055\u20136061 (2019).","journal-title":"Angew. Chem. Int. Ed."},{"key":"64432_CR24","doi-asserted-by":"publisher","first-page":"13356","DOI":"10.1002\/anie.201707819","volume":"56","author":"J Xu","year":"2017","unstructured":"Xu, J. et al. In vivo X-ray imaging of transport of renal clearable gold nanoparticles in the kidneys. Angew. Chem. Int. Ed. 56, 13356\u201313360 (2017).","journal-title":"Angew. Chem. Int. Ed."},{"key":"64432_CR25","doi-asserted-by":"publisher","first-page":"11713","DOI":"10.1002\/anie.202017273","volume":"60","author":"Y Tan","year":"2021","unstructured":"Tan, Y., Chen, M., Chen, H., Wu, J. & Liu, J. Enhanced ultrasound contrast of renal-clearable luminescent gold nanoparticles. Angew. Chem. Int. Ed. 60, 11713\u201311717 (2021).","journal-title":"Angew. Chem. Int. Ed."},{"key":"64432_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5478708","volume":"2020","author":"M Gyur\u00e1szov\u00e1","year":"2020","unstructured":"Gyur\u00e1szov\u00e1, M., Gureck\u00e1, R., B\u00e1b\u00ed\u010dkov\u00e1, J. & T\u00f3thov\u00e1, \u013d Oxidative stress in the pathophysiology of kidney disease: implications for noninvasive monitoring and identification of biomarkers. Oxid. Med. Cell. Longev. 2020, 5478708 (2020).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"64432_CR27","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41551-018-0317-8","volume":"2","author":"D Jiang","year":"2018","unstructured":"Jiang, D. et al. DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury. Nat. Biomed. Eng. 2, 865\u2013877 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"64432_CR28","doi-asserted-by":"publisher","first-page":"23522","DOI":"10.1021\/jacs.2c10323","volume":"144","author":"Y Xu","year":"2022","unstructured":"Xu, Y. et al. NIR-II photoacoustic-active DNA origami nanoantenna for early diagnosis and smart therapy of acute kidney injury. J. Am. Chem. Soc. 144, 23522\u201323533 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"64432_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07890-8","volume":"9","author":"D Ni","year":"2018","unstructured":"Ni, D. et al. Molybdenum-based nanoclusters act as antioxidants and ameliorate acute kidney injury in mice. Nat. Commun. 9, 5421 (2018).","journal-title":"Nat. Commun."},{"key":"64432_CR30","doi-asserted-by":"publisher","first-page":"2000420","DOI":"10.1002\/advs.202000420","volume":"7","author":"ZT Rosenkrans","year":"2020","unstructured":"Rosenkrans, Z. T. et al. Selenium-doped carbon quantum dots act as broad-spectrum antioxidants for acute kidney injury management. Adv. Sci. 7, 2000420 (2020).","journal-title":"Adv. Sci."},{"key":"64432_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21714-2","volume":"12","author":"Q Weng","year":"2021","unstructured":"Weng, Q. et al. Catalytic activity tunable ceria nanoparticles prevent chemotherapy-induced acute kidney injury without interference with chemotherapeutics. Nat. Commun. 12, 1436 (2021).","journal-title":"Nat. Commun."},{"key":"64432_CR32","doi-asserted-by":"publisher","first-page":"850813","DOI":"10.3389\/fphar.2022.850813","volume":"13","author":"TT Fu","year":"2022","unstructured":"Fu, T. T. & Shen, L. Ergothioneine as a natural antioxidant against oxidative stress-related diseases. Front. Pharmacol. 13, 850813 (2022).","journal-title":"Front. Pharmacol."},{"key":"64432_CR33","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.biopha.2006.07.015","volume":"60","author":"F Franzoni","year":"2006","unstructured":"Franzoni, F. et al. An in vitro study on the free radical scavenging capacity of ergothioneine: comparison with reduced glutathione, uric acid and trolox. Biomed. Pharmacother. 60, 453\u2013457 (2006).","journal-title":"Biomed. Pharmacother."},{"key":"64432_CR34","doi-asserted-by":"publisher","first-page":"5951","DOI":"10.1111\/ijfs.17414","volume":"59","author":"T Wijesekara","year":"2024","unstructured":"Wijesekara, T. & Xu, B. J. Occurrence, dietary sources, quantification and bioactivities of natural antioxidant ergothioneine - a longavity vitamin?. Int. J. Food Sci. Technol. 59, 5951\u20135963 (2024).","journal-title":"Int. J. Food Sci. Technol."},{"key":"64432_CR35","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2015.05.026","volume":"86","author":"YC Hseu","year":"2015","unstructured":"Hseu, Y. C. et al. Dermato-protective properties of ergothioneine through induction of Nrf2\/ARE-mediated antioxidant genes in UVA-irradiated Human keratinocytes. Free Radic. Bio. Med. 86, 102\u2013117 (2015).","journal-title":"Free Radic. Bio. Med."},{"key":"64432_CR36","doi-asserted-by":"publisher","first-page":"111921","DOI":"10.1016\/j.biopha.2021.111921","volume":"141","author":"A Dare","year":"2021","unstructured":"Dare, A., Channa, M. L. & Nadar, A. L-ergothioneine and its combination with metformin attenuates renal dysfunction in type-2 diabetic rat model by activating Nrf2 antioxidant pathway. Biomed. Pharmacother. 141, 111921 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"64432_CR37","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/1873-3468.14269","volume":"596","author":"D Gr\u00fcndemann","year":"2022","unstructured":"Gr\u00fcndemann, D., Hartmann, L. & Fl\u00f6gel, S. The ergothioneine transporter (ETT): substrates and locations, an inventory. FEBS Lett. 596, 1252\u20131269 (2022).","journal-title":"FEBS Lett."},{"key":"64432_CR38","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/ng1267","volume":"35","author":"S Tokuhiro","year":"2003","unstructured":"Tokuhiro, S. et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet. 35, 341\u2013348 (2003).","journal-title":"Nat. Genet."},{"key":"64432_CR39","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.kint.2017.04.032","volume":"92","author":"Y Shinozaki","year":"2017","unstructured":"Shinozaki, Y. et al. Impairment of the carnitine\/organic cation transporter 1-ergothioneine axis is mediated by intestinal transporter dysfunction in chronic kidney disease. Kidney Int. 92, 1356\u20131369 (2017).","journal-title":"Kidney Int"},{"key":"64432_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1021\/mp0340082","volume":"1","author":"I Tamai","year":"2004","unstructured":"Tamai, I. et al. Involvement of OCTN1 (SLC22A4) in pH-dependent transport of organic cations. Mol. Pharmaceutics 1, 57\u201366 (2004).","journal-title":"Mol. Pharmaceutics"},{"key":"64432_CR41","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1073\/pnas.0408624102","volume":"102","author":"D Gr\u00fcndemann","year":"2005","unstructured":"Gr\u00fcndemann, D. et al. Discovery of the ergothioneine transporter. Proc. Natl. Acad. Sci. USA. 102, 5256\u20135261 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"64432_CR42","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/nbt1340","volume":"25","author":"H Soo Choi","year":"2007","unstructured":"Soo Choi, H. et al. Renal clearance of quantum dots. Nat. Biotechnol. 25, 1165\u20131170 (2007).","journal-title":"Nat. Biotechnol."},{"key":"64432_CR43","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.1021\/ja401612x","volume":"135","author":"J Liu","year":"2013","unstructured":"Liu, J. et al. Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance. J. Am. Chem. Soc. 135, 4978\u20134981 (2013).","journal-title":"J. Am. Chem. Soc."},{"key":"64432_CR44","doi-asserted-by":"publisher","first-page":"12572","DOI":"10.1002\/anie.201304465","volume":"52","author":"J Liu","year":"2013","unstructured":"Liu, J. et al. PEGylation and Zwitterionization: pros and cons in the renal clearance and tumor targeting of near-IR-emitting gold nanoparticles. Angew. Chem. Int. Ed. 52, 12572\u201312576 (2013).","journal-title":"Angew. Chem. Int. Ed."},{"key":"64432_CR45","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/s41563-020-0755-z","volume":"19","author":"B Ouyang","year":"2020","unstructured":"Ouyang, B. et al. The dose threshold for nanoparticle tumour delivery. Nat. Mater. 19, 1362\u20131371 (2020).","journal-title":"Nat. Mater."},{"key":"64432_CR46","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/anie.201710584","volume":"57","author":"J Xu","year":"2018","unstructured":"Xu, J. et al. Dose dependencies and biocompatibility of renal clearable gold nanoparticles: from mice to non-human primates. Angew. Chem. Int. Ed. 57, 266\u2013271 (2018).","journal-title":"Angew. Chem. Int. Ed."},{"key":"64432_CR47","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41565-023-01366-7","volume":"18","author":"Y Huang","year":"2023","unstructured":"Huang, Y., Yu, M. & Zheng, J. Proximal tubules eliminate endocytosed gold nanoparticles through an organelle-extrusion-mediated self-renewal mechanism. Nat. Nanotechnol. 18, 637\u2013646 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"64432_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair, A. B. & Jacob, S. A simple practice guide for dose conversion between animals and human. J. Basic Clin. Pharm. 7, 27\u201331 (2016).","journal-title":"J. Basic Clin. Pharm."},{"key":"64432_CR49","doi-asserted-by":"publisher","first-page":"25081","DOI":"10.1021\/acsnano.4c06705","volume":"18","author":"Y Dong","year":"2024","unstructured":"Dong, Y. et al. Gram-scale synthesis of renal-clearable tantalum nanodots with high water solubility for computed tomography imaging in vivo. ACS Nano 18, 25081\u201325095 (2024).","journal-title":"ACS Nano"},{"key":"64432_CR50","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/s41563-019-0378-4","volume":"18","author":"J Huang","year":"2019","unstructured":"Huang, J., Li, J., Lyu, Y., Miao, Q. & Pu, K. Molecular optical imaging probes for early diagnosis of drug-induced acute kidney injury. Nat. Mater. 18, 1133\u20131143 (2019).","journal-title":"Nat. Mater."},{"key":"64432_CR51","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1021\/acs.bioconjchem.4c00312","volume":"35","author":"Y Peng","year":"2024","unstructured":"Peng, Y. et al. Early detection and noninvasive staging of kidney dysfunction by a PEGylated conventional fluorophore via GFR-sensitive renal transport. Bioconjugate Chem. 35, 1258\u20131268 (2024).","journal-title":"Bioconjugate Chem."},{"key":"64432_CR52","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1097\/00004424-199405001-00013","volume":"29","author":"JH Newhouse","year":"1994","unstructured":"Newhouse, J. H. et al. Efficacy and safety of iopromide for excretory urography. Invest. Radiol. 29, S68\u2013S73 (1994).","journal-title":"Invest. Radiol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64432-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64432-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64432-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T11:03:54Z","timestamp":1761131034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64432-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64432"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64432-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.D., M.X. and X.J. are inventors on patent applications (CN: ZL202411455898.1, US: 19\/212,792) for the development and applications of E-Au-Agent reported in this study. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9346"}}